BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34402503)

  • 1. LncRNA SRA mediates cell migration, invasion, and progression of ovarian cancer via NOTCH signaling and epithelial-mesenchymal transition.
    Kim LK; Park SA; Yang Y; Kim YT; Heo TH; Kim HJ
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34402503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.
    Eoh KJ; Paek J; Kim SW; Kim HJ; Lee HY; Lee SK; Kim YT
    Oncol Rep; 2017 Dec; 38(6):3481-3488. PubMed ID: 29039612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F8 Induces Cell Proliferation and Invasion through the Epithelial-Mesenchymal Transition and Notch Signaling Pathways in Ovarian Cancer.
    Eoh KJ; Kim HJ; Lee JW; Kim LK; Park SA; Kim HS; Kim YT; Koo PJ
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
    Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Long Noncoding RNA H19 Downregulates miR-140-5p and Activates PI3K/AKT Signaling Pathway to Promote Invasion, Migration and Epithelial-Mesenchymal Transition of Ovarian Cancer Cells.
    Xu H; Ding Y; Yang X
    Biomed Res Int; 2021; 2021():6619730. PubMed ID: 34250088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid Receptor RNA Activator, a Long Noncoding RNA, Activates p38, Facilitates Epithelial-Mesenchymal Transformation, and Mediates Experimental Melanoma Metastasis.
    Hong CH; Ho JC; Lee CH
    J Invest Dermatol; 2020 Jul; 140(7):1355-1363.e1. PubMed ID: 31945347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression.
    Zeng XY; Xie H; Yuan J; Jiang XY; Yong JH; Zeng D; Dou YY; Xiao SS
    Cancer Biol Ther; 2019; 20(7):956-966. PubMed ID: 31062668
    [No Abstract]   [Full Text] [Related]  

  • 8. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
    Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
    Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA TC0101441 induces epithelial-mesenchymal transition in epithelial ovarian cancer metastasis by downregulating KiSS1.
    Qiu JJ; Lin XJ; Tang XY; Zheng TT; Zhang XY; Hua KQ
    Int J Cancer; 2020 May; 146(9):2588-2598. PubMed ID: 31577838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lncRNA SNHG15/miR-18a-5p axis promotes cell proliferation in ovarian cancer through activating Akt/mTOR signaling pathway.
    Zhang J; Wang L; Jiang J; Qiao Z
    J Cell Biochem; 2020 Dec; 121(12):4699-4710. PubMed ID: 33135285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 12. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the Notch signaling pathway attenuates progression of cell motility, metastasis, and epithelial-to-mesenchymal transition-like phenomena induced by low concentrations of cisplatin in osteosarcoma.
    Dai G; Liu G; Zheng D; Song Q
    Eur J Pharmacol; 2021 May; 899():174058. PubMed ID: 33757752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
    Cheng Z; Guo J; Chen L; Luo N; Yang W; Qu X
    Oncotarget; 2015 Sep; 6(28):25381-9. PubMed ID: 26299803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.
    Yan H; Li H; Li P; Li X; Lin J; Zhu L; Silva MA; Wang X; Wang P; Zhang Z
    J Exp Clin Cancer Res; 2018 Sep; 37(1):237. PubMed ID: 30249278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA AC005224.4/miR-140-3p/SNAI2 regulating axis facilitates the invasion and metastasis of ovarian cancer through epithelial-mesenchymal transition.
    Xiong T; Wang Y; Zhang Y; Yuan J; Zhu C; Jiang W
    Chin Med J (Engl); 2023 May; 136(9):1098-1110. PubMed ID: 36939239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. lncRNA MIAT Regulates Cell Growth, Migration, and Invasion Through Sponging miR-150-5p in Ovarian Cancer.
    Zhou S; Xu A; Song T; Gao F; Sun H; Kong X
    Cancer Biother Radiopharm; 2020 Nov; 35(9):650-660. PubMed ID: 32186927
    [No Abstract]   [Full Text] [Related]  

  • 18. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway.
    Gao K; Ji Z; She K; Yang Q; Shao L
    Biomed Pharmacother; 2017 Mar; 87():555-560. PubMed ID: 28081466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid receptor RNA activator inhibits the migration, invasion and stemness characteristics of renal cell carcinoma cells.
    Zhang C; Zhu N; Liu C; Wu H; Yin Y; Shi Y; Liao D; Qin L
    Int J Mol Med; 2020 Nov; 46(5):1765-1776. PubMed ID: 33000206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.